by Andreu Prados
Bacteria and fungi in the human gut microbiota may contribute to the underlying mechanisms of IBS, which means the latter can be explored as a potential target for IBS. This article explores what is known about the role of the gut microbiome and yeast probiotics in irritable bowel syndrome.
by Allison Clark
The purpose of the article is to uncover how dietary components and long-term dietary patterns interact with and influence gut microbiota composition and function and intestinal inflammation.
by Joël Doré
Little is known about the relationship between diet, the composition and function of the gut microbiota and clinical symptoms of IBS. New findings identify how IBS symptom severity is related to a higher intake of foods with poor nutritional quality and gut microbiome features at both subspecies level and metabolic pathways involved in carbohydrate metabolism.
by Andreu Prados
The low FODMAP diet has been shown to be effective in managing the symptoms of IBS as second-line dietary advice when healthy eating approaches have failed to reduce symptoms. However, this eliminative diet is not without its challenges, which can be overcome by following the advice found below.
by GMFH Editing Team
A wide range of factors are involved in driving the onset of IBS, with certain food items considered important triggers. Learn more about the latest scientific evidence regarding dietary management of IBS in this narrative review.
by Numan Oezguen, James Versalovic
An accurate diagnosis of patients with IBS remains a challenge because it relies largely on clinical criteria. Now scientists have developed an improved disease classification technique that enables personalized diagnosis of pediatric patients with IBS based on their gut microbiome.
Personalized nutrition is still in its infancy but it is an increasingly important area of research that may one day help us better plan nutritional interventions to ensure a better response from patients.
by Allison Clark
An individual’s gut microbiota composition might be used in predicting responses to dietary interventions. However, there’s still inconsistent evidence to support the existence of signature gut microbiota compositions that predict clinical response to diet in obese and IBS patients.
by Allison Clark
A recent study by Philippe Marteau has analyzed and evaluated the speed at which abdominal discomfort improves after a fermented milk product (FMP) is consumed.
Recent research has shown the gut microbiota’s importance for gut health while confirming that diet remains one of the most powerful ways to influence this gut microbial balance.
